Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Akero Therapeutics (AKRO) Q3 2025 Earnings
AKRO
8
Aug
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.16
-1.06
-0.96
-0.86
Details
Expected EPS
-0.917119
Actual EPS
-0.86
Surprise EPS
0.06
Surprise Percent
+6.23%
Description
Akero Therapeutics (AKRO) has reported earnings of -0.86 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login